China’s efforts to ramp up the country’s biotechnology capabilities are outpacing progress to strengthen laboratory safety, prompting concerns that a deadly pathogen could escape the laboratory setting and potentially spur another pandemic, experts told The Washington Post.
Read the full post on Becker's Hospital Review - Healthcare News
